ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

0RQE Idorsia Ltd

1.9775
0.00 (0.00%)
Última actualización: 19:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Idorsia Ltd 0RQE London Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 1.9775 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.9775
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
17/4/202400:00UKREGIdorsia publishes a Financial Status required for an..
17/4/202400:00UKREGIdorsia publishes a Financial Status required for an..
11/4/202400:00UKREGIdorsia takes steps to address short-term liquidity needs
11/4/202400:00UKREGIdorsia takes steps to address short-term liquidity needs
22/3/202401:00UKREGIdorsia thanks Guy Braunstein for his years of service as he..
22/3/202401:00UKREGIdorsia thanks Guy Braunstein for his years of service as he..
20/3/202401:00UKREGUS FDA approves Idorsia’s once-daily TRYVIO (aprocitentan) –..
20/3/202401:00UKREGUS FDA approves Idorsia’s once-daily TRYVIO (aprocitentan) –..
18/3/202401:00UKREGIdorsia and Viatris successfully close the transaction for..
18/3/202401:00UKREGIdorsia and Viatris successfully close the transaction for..
28/2/202400:00UKREGIdorsia and Viatris enter into a significant global research..
28/2/202400:00UKREGIdorsia and Viatris enter into a significant global research..
10/1/202400:00GLOBEIdorsia presents at the J.P. Morgan Healthcare Conference –..
03/11/202316:30GLOBENew Phase 3 data with aprocitentan for patients with..
24/10/202300:00GLOBEIdorsia announces financial results for the first nine..
23/10/202300:00GLOBEIdorsia is committed to further the science of sleep with a..
17/10/202310:45GLOBEInvitation to Idorsia's Nine-Month 2023 Financial Reporting..
06/9/202300:00GLOBEIdorsia reacquires the world-wide rights to aprocitentan
25/7/202300:00GLOBEIdorsia announces financial results for the first half 2023..
21/7/202300:00GLOBEIdorsia announces a cost reduction initiative to be..
20/7/202301:30GLOBEIdorsia sells its Asia Pacific (ex-China) operations –..
18/7/202310:45GLOBEInvitation to Idorsia's HY 2023 Financial Results webcast..
10/7/202300:00GLOBEIdorsia announces its insomnia medication, QUVIVIQ..
26/6/202310:45GLOBENew Phase 3 data with aprocitentan for patients with..
23/6/202310:45GLOBENew Phase 3 data with aprocitentan to be presented at the..
20/6/202300:00GLOBEIdorsia has secured bridge financing in the amount of CHF..
12/6/202300:00GLOBEIdorsia bringt QUVIVIQ (Daridorexant) in der Schweiz auf den..
06/6/202300:00GLOBEIdorsia has entered into exclusive negotiations with regard..
30/5/202300:00GLOBEIdorsia announces a change to commercial leadership
04/5/202304:16GLOBEIdorsia holds its Annual General Meeting of Shareholders
03/5/202300:00GLOBEHealth Canada approves QUVIVIQ (daridorexant) for the..
25/4/202300:00GLOBEIdorsia announces financial results for the first quarter..

Su Consulta Reciente

Delayed Upgrade Clock